Description
KB-0742 is a selective CDK9 inhibitor with potent anti-tumor activity in castration-resistant prostate cancer models.
| Product Unit Size | Cost | Quantity | Stock |
|---|
KB-0742 is a selective CDK9 inhibitor with potent anti-tumor activity in castration-resistant prostate cancer models.
| Cas No. | 2170137-61-6 (free base) |
|---|---|
| Purity | ≥98% |
| Formula | C16H25N5 |
| Formula Wt. | 287.41 |
| IUPAC Name | (1S,3S)-3-N-(5-pentan-3-ylpyrazolo[1,5-a]pyrimidin-7-yl)cyclopentane-1,3-diamine |
| Synonym | KB0742, NSC-834161, NSC834161 |
| Appearance | Yellow to brown crystal |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Richters A, Doyle S, Freeman D, et al. Modulating androgen receptor-driven transcription in prostate cancer with selective CDK9 inhibitors. Cell Chem Biol. 2021 Feb 18;28(2):134-147. PMID: 33086052
Mixture of oligomycins A, B, C; oxidative phosp...
Ca2+ sensitizer; ATP-sensitive K+ channel activ...
Mycotoxin that has structural similarity to est...
ANP fragment, natriuretic peptide; Na+/K+ ATPas...
Endogenous peptide hormone fragment, involved i...
Fluoroquinolone; bacterial DNA gyrase inhibitor...
NSAID; COX-1/2 and lipoxygenase inhibitor.
Side chain attached to various taxanes.
Abl inhibitor.
Hydroxypyridone, metal ion chelator; mTOR inhib...
Recombinant HIV-1 glycoprotein antigen fragment...
Cysteine-ITC conjugate, antioxidant; aldehyde d...
Multikinase inhibitor.
Jumonji histone demethylase inhibitor.
Galactose-derived hexosamine sugar, component o...
Fumaric acid methyl ester; nAChR agonist, indir...
Diterpene vitamin A; RAR/RXR agonist.
Proteasome inhibitor.
Prevents MHC II antigen presentation.
Macrocyclic lactone.